Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1989 Nov;84(5):1479–1487. doi: 10.1172/JCI114323

Sulfated beef insulin treatment elicits CD8+ T cells that may abrogate immunologic insulin resistance in type I diabetes.

P Naquet 1, J Ellis 1, A Kenshole 1, J W Semple 1, T L Delovitch 1
PMCID: PMC304012  PMID: 2530249

Abstract

The in vitro responses of T cells from 13 insulin-nonresistant and 1 immunologically insulin-resistant (IIR) type I diabetes patients to sulfated beef insulin (SBI) were analyzed. Insulin A-loop specific CD4+ T cells from these patients did not respond to SBI. After 1 yr of treatment with SBI the IIR patient's T cell and antibody responses to beef, pork, and human insulin progressed from very high to nondetectable levels. This occurred in parallel to the appearance of her insulin-specific CD8+ T cells, which inhibited the response of her A-loop-specific CD4+ T cells to insulin. A transient increase in her CD8+ anti-insulin antibody activity coincided with a relative lack of her CD8+ T cell activity. CD8+ T cells that regulate T cell responsiveness to insulin are probably present but difficult to detect in most type I diabetes patients. These T cells were identified in only 2 of 13 insulin-nonresistant patients who presented with lipoatrophy and insulin allergy, respectively, and who possessed high-titered, anti-insulin antibodies. Our data demonstrate that CD8+ T cells play an important role in controlling peripheral tolerance to insulin and may abrogate IIR in a diabetic patient treated with SBI.

Full text

PDF
1479

Images in this article

1481Image
on p.1481

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Benaroch P., Georgatsou E., Bordenave G. Cellular induction of chronic allotype suppression of IgG2a in Ighb/b homozygous mice and its abrogation by in vivo treatment with anti-CD8 monoclonal antibody. J Exp Med. 1988 Sep 1;168(3):891–904. doi: 10.1084/jem.168.3.891. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bloom B. R., Mehra V. Immunological unresponsiveness in leprosy. Immunol Rev. 1984 Aug;80:5–28. doi: 10.1111/j.1600-065x.1984.tb00493.x. [DOI] [PubMed] [Google Scholar]
  3. Brange J., Ribel U., Hansen J. F., Dodson G., Hansen M. T., Havelund S., Melberg S. G., Norris F., Norris K., Snel L. Monomeric insulins obtained by protein engineering and their medical implications. Nature. 1988 Jun 16;333(6174):679–682. doi: 10.1038/333679a0. [DOI] [PubMed] [Google Scholar]
  4. Davidson J. K., DeBra D. W. Immunologic insulin resistance. Diabetes. 1978 Mar;27(3):307–318. doi: 10.2337/diab.27.3.307. [DOI] [PubMed] [Google Scholar]
  5. Glimcher L. H., Schroer J. A., Chan C., Shevach E. M. Fine specificity of cloned insulin-specific T cell hybridomas: evidence supporting a role for tertiary conformation. J Immunol. 1983 Dec;131(6):2868–2874. [PubMed] [Google Scholar]
  6. Jensen P. E., Kapp J. A. Stimulation of helper T cells and dominant suppressor T cells that recognize autologous insulin. J Mol Cell Immunol. 1985;2(3):133–139. [PubMed] [Google Scholar]
  7. Jensen P. E., Pierce C. W., Kapp J. A. Regulatory mechanisms in immune responses to heterologous insulins. II. Suppressor T cell activation associated with nonresponsiveness in H-2b mice. J Exp Med. 1984 Oct 1;160(4):1012–1026. doi: 10.1084/jem.160.4.1012. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Kahn C. R., Rosenthal A. S. Immunologic reactions to insulin: insulin allergy, insulin resistance, and the autoimmune insulin syndrome. Diabetes Care. 1979 May-Jun;2(3):283–295. doi: 10.2337/diacare.2.3.283. [DOI] [PubMed] [Google Scholar]
  9. Levich J. D., Weigle W. O., Parks D. E. Long-term suppressor cell lines. I. Demonstration of suppressive function. Eur J Immunol. 1984 Dec;14(12):1073–1079. doi: 10.1002/eji.1830141202. [DOI] [PubMed] [Google Scholar]
  10. Little J. A., Arnott J. H. Sulfated insulin in mild, moderate, severe and insulin-resistant diabetes mellitus. Diabetes. 1966 Jul;15(7):457–465. doi: 10.2337/diab.15.7.457. [DOI] [PubMed] [Google Scholar]
  11. MOLONEY P. J., APRILE M. A., WILSON S. SULFATED INSULIN FOR TREATMENT OF INSULIN-RESISTANT DIABETICS. J New Drugs. 1964 Sep-Oct;4(5):258–263. doi: 10.1002/j.1552-4604.1964.tb00356.x. [DOI] [PubMed] [Google Scholar]
  12. Maclaren N. K. How, when, and why to predict IDDM. Diabetes. 1988 Dec;37(12):1591–1594. doi: 10.2337/diab.37.12.1591. [DOI] [PubMed] [Google Scholar]
  13. McEvoy R. C., Witt M. E., Ginsberg-Fellner F., Rubinstein P. Anti-insulin antibodies in children with type I diabetes mellitus. Genetic regulation of production and presence at diagnosis before insulin replacement. Diabetes. 1986 Jun;35(6):634–641. doi: 10.2337/diab.35.6.634. [DOI] [PubMed] [Google Scholar]
  14. Menard L., Dempsey M. E., Blankstein L. A., Aleyassine H., Wacks M., Soeldner J. S. Quantitiative determination of glycosylated hemoglobin A1 by agar gel electrophoresis. Clin Chem. 1980 Oct;26(11):1598–1602. [PubMed] [Google Scholar]
  15. Naquet P., Ellis J., Singh B., Hodges R. S., Delovitch T. L. Processing and presentation of insulin. I. Analysis of immunogenic peptides and processing requirements for insulin A loop-specific T cells. J Immunol. 1987 Dec 15;139(12):3955–3963. [PubMed] [Google Scholar]
  16. Naquet P., Ellis J., Tibensky D., Kenshole A., Singh B., Hodges R., Delovitch T. L. T cell autoreactivity to insulin in diabetic and related non-diabetic individuals. J Immunol. 1988 Apr 15;140(8):2569–2578. [PubMed] [Google Scholar]
  17. Naquet P., Marchetto S., Pierres M. Dissection of the Poly(Glu60Ala30Tyr10) (GAT)-specific T-cell repertoire in H-2Ik mice. II. The use of monoclonal antibodies to study the recognition of Ia antigens by GAT-reactive T-cell clones. Immunogenetics. 1983;18(6):559–574. doi: 10.1007/BF00345964. [DOI] [PubMed] [Google Scholar]
  18. Nell L. J., Thomas J. W. The human immune response to insulin. I. Kinetic and cellular aspects of lymphocyte proliferative responses in diabetics. J Immunol. 1983 Aug;131(2):701–705. [PubMed] [Google Scholar]
  19. Olive D., Ragueneau M., Cerdan C., Dubreuil P., Lopez M., Mawas C. Anti-CD2 (sheep red blood cell receptor) monoclonal antibodies and T cell activation. I. Pairs of anti-T11.1 and T11.2 (CD2 subgroups) are strongly mitogenic for T cells in presence of 12-O-tetradecanoylphorbol 13-acetate. Eur J Immunol. 1986 Sep;16(9):1063–1068. doi: 10.1002/eji.1830160906. [DOI] [PubMed] [Google Scholar]
  20. Palmer J. P., Asplin C. M., Clemons P., Lyen K., Tatpati O., Raghu P. K., Paquette T. L. Insulin antibodies in insulin-dependent diabetics before insulin treatment. Science. 1983 Dec 23;222(4630):1337–1339. doi: 10.1126/science.6362005. [DOI] [PubMed] [Google Scholar]
  21. Rubin B., Geisler C., Kuhlmann J., Plesner T. Fractionation of T cell subsets on Ig anti-Ig columns: isolation of helper T cells from nonresponder mice, demonstration of antigen-specific T suppressor cells, and selection of CD-3 negative variants of Jurkat T cells. Cell Immunol. 1989 Apr 1;119(2):327–340. doi: 10.1016/0008-8749(89)90248-7. [DOI] [PubMed] [Google Scholar]
  22. SHIPP J. C., CUNNINGHAM R. W., RUSSELL R. O., MARBLE A. INSULIN RESISTANCE: CLINICAL FEATURES, NATURAL COURSE AND EFFECTS OF ADRENAL STEROID TREATMENT. Medicine (Baltimore) 1965 Mar;44:165–186. [PubMed] [Google Scholar]
  23. Sebriakova M., Little J. A. A method for the determination of plasma insulin antibodies and its application in normal and diabetic subjects. Diabetes. 1973 Jan;22(1):30–40. doi: 10.2337/diab.22.1.30. [DOI] [PubMed] [Google Scholar]
  24. Shinohara N., Watanabe M., Sachs D. H., Hozumi N. Killing of antigen-reactive B cells by class II-restricted, soluble antigen-specific CD8+ cytolytic T lymphocytes. Nature. 1988 Dec 1;336(6198):481–484. doi: 10.1038/336481a0. [DOI] [PubMed] [Google Scholar]
  25. Sun D., Qin Y., Chluba J., Epplen J. T., Wekerle H. Suppression of experimentally induced autoimmune encephalomyelitis by cytolytic T-T cell interactions. Nature. 1988 Apr 28;332(6167):843–845. doi: 10.1038/332843a0. [DOI] [PubMed] [Google Scholar]
  26. Wysocki L. J., Sato V. L. "Panning" for lymphocytes: a method for cell selection. Proc Natl Acad Sci U S A. 1978 Jun;75(6):2844–2848. doi: 10.1073/pnas.75.6.2844. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES